Missouri Patent of the Month – October 2024
Biomed Valley Discoveries has introduced a groundbreaking approach to treating melanoma with NRAS mutations, leveraging a powerful synergistic combination of anti-cancer agents. The method pairs BVD-523, a selective inhibitor targeting the MAPK pathway, with LEE-011, a CDK inhibitor. This combination amplifies their effectiveness compared to using either agent alone, marking a significant step forward in overcoming the limitations of current cancer therapies.
Melanoma and other cancers with RAS mutations present a persistent challenge due to their aggressive nature and resistance to traditional treatments. Targeting the MAPK signaling pathway—a critical regulator of cell growth and survival—offers a promising therapeutic avenue. BVD-523 effectively disrupts this pathway by inhibiting downstream signaling, while LEE-011 halts cell cycle progression, attacking cancer cells from two angles.
This innovative combination therapy not only curtails tumor growth but also enhances cancer cell death, addressing both proliferation and survival mechanisms. Its versatility allows for further customization, as additional therapeutic agents, such as immunomodulators or anti-angiogenesis compounds, can complement the treatment for more robust results.
Research highlights the durability of this dual-action approach. In preclinical studies, prolonged exposure to BVD-523 demonstrated consistent inhibition of MAPK feedback mechanisms, while LEE-011 effectively suppressed cyclin D1, a key regulator in cancer cell proliferation. This combination achieved notable reductions in tumor progression while maintaining a manageable side-effect profile.
Biomed Valley Discoveries’ innovative treatment strategy not only provides hope for those battling melanoma but also opens new doors for addressing other RAS-driven cancers. By integrating precision-targeted therapies, this invention reflects the forefront of cancer research, aiming to improve survival rates and enhance the quality of life for patients worldwide.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
